|
1
|
Zhang B, Cai FF and Zhong XY: An overview
of biomarkers for the ovarian cancer diagnosis. Eur J Obstet
Gynecol Reprod Biol. 158:119–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim JH, Park CW, Um D, Baek KH, Jo Y, An
H, Kim Y and Kim TJ: Mass spectrometric screening of ovarian cancer
with serum glycans. Dis Markers. 2014:6342892014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Corney DC, Hwang CI, Matoso A, Vogt M,
Flesken-Nikitin A, Godwin AK, Kamat AA, Sood AK, Ellenson LH,
Hermeking H and Nikitin AY: Frequent downregulation of miR-34
family in human ovarian cancers. Clin Cancer Res. 16:1119–1128.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ye SB, Li ZL, Luo DH, Huang BJ, Chen YS,
Zhang XS, Cui J, Zeng YX and Li J: Tumor-derived exosomes promote
tumor progression and T-cell dysfunction through the regulation of
enriched exosomal microRNAs in human nasopharyngeal carcinoma.
Oncotarget. 5:5439–5452. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yuan H and Gao Y: MicroRNA-1908 is
upregulated in human osteosarcoma and regulates cell proliferation
and migration by repressing PTEN expression. Oncol Rep.
34:2706–2714. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rawlings-Goss RA, Campbell MC and Tishkoff
SA: Global population-specific variation in miRNA associated with
cancer risk and clinical biomarkers. BMC Med Genomics. 7:532014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miles GD, Seiler M, Rodriguez L, Rajagopal
G and Bhanot G: Identifying microRNA/mRNA dysregulations in ovarian
cancer. BMC Res Notes. 5:1642012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lian D, Wang ZZ and Liu NS: MicroRNA-1908
is a biomarker for poor prognosis in human osteosarcoma. Eur Rev
Med Pharmacol Sci. 20:1258–1262. 2016.PubMed/NCBI
|
|
9
|
Xie C, Shi K, Zhang X, Zhao J and Yu J:
MiR-1908 promotes scar formation post-burn wound healing by
suppressing Ski-mediated inflammation and fibroblast proliferation.
Cell Tissue Res. 366:371–380. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xia X, Li Y, Wang W, Tang F, Tan J, Sun L,
Li Q, Sun L, Tang B and He S: MicroRNA-1908 functions as a
glioblastoma oncogene by suppressing PTEN tumor suppressor pathway.
Mol Cancer. 14:1542015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu G, Xue F and Zhang W: miR-506: A
regulator of chemo-sensitivity through suppression of the
RAD51-homologous recombination axis. Chin J Cancer. 34:485–487.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shou J, Gu S and Gu W: Identification of
dysregulated miRNAs and their regulatory signature in glioma
patients using the partial least squares method. Exp Ther Med.
9:167–171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ghanbari M, Sedaghat S, de Looper HW,
Hofman A, Erkeland SJ, Franco OH and Dehghan A: The association of
common polymorphisms in miR-196a2 with waist to hip ratio and
miR-1908 with serum lipid and glucose. Obesity (Silver Spring).
23:495–503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Long C, Jiang L, Wei F, Ma C, Zhou H, Yang
S, Liu X and Liu Z: Integrated miRNA-mRNA analysis revealing the
potential roles of miRNAs in chordomas. PLoS One. 8:e666762013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pencheva N, Tran H, Buss C, Huh D,
Drobnjak M, Busam K and Tavazoie SF: Convergent multi-miRNA
targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis
and angiogenesis. Cell. 151:1068–1082. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gerhard DS, Wagner L, Feingold EA, Shenmen
CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, et
al: The status, quality, and expansion of the NIH full-length cDNA
project: The Mammalian Gene Collection (MGC). Genome Res.
14:2121–2127. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kilic Eren M, Kilincli A and Eren Ö:
Resveratrol induced premature senescence is associated with DNA
damage mediated SIRT1 and SIRT2 down-regulation. PLoS One.
10:e01248372015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grbesa I, Pajares MJ, Martinez-Terroba E,
Agorreta J, Mikecin AM, Larráyoz M, Idoate MA, Gall-Troselj K, Pio
R and Montuenga LM: Expression of sirtuin 1 and 2 is associated
with poor prognosis in non-small cell lung cancer patients. PLoS
One. 10:e01246702015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kurat CF, Lambert JP, Petschnigg J,
Friesen H, Pawson T, Rosebrock A, Gingras AC, Fillingham J and
Andrews B: Cell cycle-regulated oscillator coordinates core histone
gene transcription through histone acetylation. Proc Natl Acad Sci
USA. 111:14124–14129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Atsaves V, Lekakis L, Drakos E, Leventaki
V, Ghaderi M, Baltatzis GE, Chioureas D, Jones D, Feretzaki M,
Liakou C, et al: The oncogenic JUNB/CD30 axis contributes to cell
cycle deregulation in ALK+ anaplastic large cell lymphoma. Br J
Haematol. 167:514–523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Salmanidis M, Brumatti G, Narayan N, Green
BD, van den Bergen JA, Sandow JJ, Bert AG, Silke N, Sladic R,
Puthalakath H, et al: Hoxb8 regulates expression of microRNAs to
control cell death and differentiation. Cell Death Differ.
20:1370–1380. 2013. View Article : Google Scholar : PubMed/NCBI
|
